PE/VC Fundraising - Acquisitions & Exits - Funding Rounds - Tell us about your Deals - Sign up for Newsletter

Versant Ventures

NousCom Raises €42M Serie B Financing

Versant Ventures Closes Sixth Healthcare Fund at $400 million

Swiss/Italian biotech Nouscom closes €12M Series A from LSP and Versant Ventures

Swedish Cancer Company Aprea Closes €46M Series B co-led by Versant and 5AM

Therachon, achondroplasia therapy developer, raises $35M in Series A round, led by OrbiMed

PIQUR Therapeutics AG, a Swiss clinical-stage pharmaceutical company, raises CHF 18M in Series A2 financing

Autonomic Technologies, the developer of a microstimulator to treat severe headaches, secures a $38M series D round

CRISPR Therapeutics, a biopharmaceutical company, raises additional $64M